DCLK3
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
doublecortin like kinase 3 | MIM:613167 | Ensembl:ENSG00000163673 | HGNC:HGNC:19005 | PA162383403 | 3p22.2 |
GO terms in DCLK3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0004672 | protein kinase activity |
MF | IEA | GO:0005524 | ATP binding |
CC | IBA | GO:0005634 | nucleus |
CC | IEA | GO:0005634 | nucleus |
CC | IBA | GO:0005737 | cytoplasm |
BP | IBA | GO:0018105 | peptidyl-serine phosphorylation |
BP | IEA | GO:1900181 | negative regulation of protein localization to nucleus |
Gene expression in normal tissue: DCLK3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in DCLK3
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD599 | Salermide | 3 |
iGMDRD889 | Compound 7d-cis | 3 |
iGMDRD248 | BRD4354 | 2 |
iGMDRD772 | BRD4770 | 3 |
iGMDRD151 | CHM-1 | 2 |
iGMDRD79 | Gemcitabine | 2 |
iGMDRD546 | BMS-754807 | 2 |
iGMDRD427 | ABT737 | 4 |
iGMDRD351 | GW843682X | 4 |
iGMDRD85 | Ursolic acid | 5 |
iGMDRD375 | GW-405833 | 2 |
iGMDRD435 | BI-2536 | 2 |
iGMDRD123 | Isoevodiamine | 2 |
iGMDRD270 | Ciclosporin | 2 |
iGMDRD121 | GMX1778 | 3 |
iGMDRD441 | TW 37 | 3 |
iGMDRD52 | Rotenone | 3 |
iGMDRD870 | BRD63610 | 2 |
iGMDRD434 | BMS-536924 | 1 |
iGMDRD888 | Compound 44 | 3 |
iGMDRD506 | Fedratinib | 2 |
iGMDRD398 | Sepantronium | 4 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD23 | Gossypol | 3 |
iGMDRD322 | FK 866 | 5 |
iGMDRD300 | Tozasertib | 1 |
iGMDRD246 | NPC26 | 2 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in DCLK3